Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference

The inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? These questions will be answered along with unique insights including HPAPI manufacturing technologies.

Attend the conference and join the networking platform with industry professionals to provide you with the expertise to overcome challenges.

Discussion highlights

Oncology Antibody-Drug Conjugates (ADC), the ongoing developments and the containment challenges imposed.

How to correctly assess, plan and implement the most cost-effective containment.

Emerging HPAPI therapies, oncolytic viruses their potential and challenges.

Alternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com.